{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:25:40Z","timestamp":1785929140405,"version":"3.56.0"},"reference-count":231,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pbb.2024.173878","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T06:23:54Z","timestamp":1726295034000},"page":"173878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Anxiety and the brain: Neuropeptides as emerging factors"],"prefix":"10.1016","volume":"245","author":[{"given":"Kiran S.","family":"Satao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8490-0705","authenticated-orcid":false,"given":"Gaurav M.","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2024.173878_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molbrainres.2005.03.016","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene","volume":"138","author":"Agarwal","year":"2005","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0010","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0031-9384(96)00156-4","article-title":"Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test","volume":"60","author":"Aguiar","year":"1996","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2024.173878_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-0115(00)00196-8","article-title":"Vasopressinergic regulation of the hypothalamic\u2013pituitary\u2013adrenal axis: implications for stress adaptation","volume":"96","author":"Aguilera","year":"2000","journal-title":"Regul. Pept."},{"key":"10.1016\/j.pbb.2024.173878_bb0020","article-title":"THE CONCISE GUIDE TO PHARMACOLOGY 2017\/18: overview","volume":"174","author":"Alexander","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173878_bb0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ajmg.b.32145","article-title":"ADCYAP1R1 genotype associates with post-traumatic stress symptoms in highly traumatized African-American females","volume":"162","author":"Almli","year":"2013","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pbb.2024.173878_bb0030","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.pbb.2024.173878_bb0035","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2022"},{"key":"10.1016\/j.pbb.2024.173878_bb0040","doi-asserted-by":"crossref","first-page":"9680","DOI":"10.1523\/JNEUROSCI.2600-05.2005","article-title":"Lesions of the basal amygdala block expression of conditioned fear but not extinction","volume":"25","author":"Anglada-Figueroa","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0045","series-title":"Plastic Responses of the Rodent Urocortinergic Edinger-Westphal Nucleus to Stress","author":"Bal\u00e1zs Gaszner","year":"2008"},{"key":"10.1016\/j.pbb.2024.173878_bb0050","first-page":"285","article-title":"Type-A cholecystokinin binding sites in cow brain: characterization using (-)-[3H]L364718 membrane binding assays","volume":"36","author":"Barrett","year":"1989","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173878_bb0055","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4088\/JCP.13m08837","article-title":"Two-year course trajectories of anxiety disorders","volume":"75","author":"Batelaan","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173878_bb0060","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1523\/JNEUROSCI.22-12-05239.2002","article-title":"NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala","volume":"22","author":"Bauer","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbr.2016.02.020","article-title":"Vasopressin V1a, but not V1b, receptors within the PVN of lactating rats mediate maternal care and anxiety-related behaviour","volume":"305","author":"Bayerl","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archgenpsychiatry.2009.177","article-title":"Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder","volume":"67","author":"Beesdo","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173878_bb0075","series-title":"Neuropeptides in Psychiatric Diseases: An Overview with a Particular Focus on Depression and Anxiety Disorders","author":"Belzung","year":"2006"},{"key":"10.1016\/j.pbb.2024.173878_bb0080","series-title":"Insights to Neuroimmune Biology","first-page":"63","article-title":"An update on neural regulators of the hypothalamic\u2013pituitary\u2013adrenal axis","author":"Berczi","year":"2016"},{"key":"10.1016\/j.pbb.2024.173878_bb0085","series-title":"The Neuroendocrinology of Trust and Aggression Oxytocin, Vasopressin and Human Behavior","author":"Berends","year":"2022"},{"key":"10.1016\/j.pbb.2024.173878_bb0090","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.npp.1300360","article-title":"Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice","volume":"29","author":"Bielsky","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb0095","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1086\/321969","article-title":"Schizophrenia and affective disorders\u2014cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family","volume":"69","author":"Blackwood","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.pbb.2024.173878_bb0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1101\/lm.30901","article-title":"Synaptic plasticity in the lateral amygdala: a cellular hypothesis of fear conditioning","volume":"8","author":"Blair","year":"2001","journal-title":"Learn. Mem."},{"key":"10.1016\/j.pbb.2024.173878_bb0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.neuroscience.2005.02.043","article-title":"The lateral amygdala processes the value of conditioned and unconditioned aversive stimuli","volume":"133","author":"Blair","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2024.173878_bb0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00213-008-1354-x","article-title":"Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior","volume":"202","author":"Bleickardt","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2024.173878_bb0115","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1432-1327.1999.00599.x","article-title":"Isolation and characterization of sulphated and nonsulphated forms of cholecystokinin-58 and their action on gallbladder contraction","volume":"264","author":"Bonetto","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.pbb.2024.173878_bb0120","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1460-9568.2010.07115.x","article-title":"Vasopressin released within the central amygdala promotes maternal aggression","volume":"31","author":"Bosch","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0125","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0028-3908(01)00051-X","article-title":"Intra-amygdala injection of the substance P (NK1 receptor) antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs","volume":"41","author":"Boyce","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb0130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.1991.01810310021005","article-title":"Enhanced sensitivity to cholecystokinin Tetrapeptide in panic disorder","volume":"48","author":"Bradwejn","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173878_bb0135","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1111\/j.1742-4658.2006.05221.x","article-title":"Neuropeptide Y-family receptors Y 6 and Y 7 in chicken","volume":"273","author":"Brom\u00e9e","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.pbb.2024.173878_bb0140","doi-asserted-by":"crossref","DOI":"10.1007\/BF00212323","article-title":"Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat","volume":"192","author":"Buijs","year":"1978","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0145","series-title":"What Are Neuropeptides?","first-page":"1","author":"Burbach","year":"2011"},{"key":"10.1016\/j.pbb.2024.173878_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2007.10.007","article-title":"Vasopressin: behavioral roles of an \u201coriginal\u201d neuropeptide","volume":"84","author":"Caldwell","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pbb.2024.173878_bb0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1385\/JMN:28:3:239","article-title":"Emotional behavior in aged neuropeptide Y (NPY) Y<sub>2<\/sub> knockout mice","volume":"28","author":"Carvajal","year":"2006","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0160","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/syn.890060306","article-title":"Long-term synaptic potentiation in the amygdala","volume":"6","author":"Chapman","year":"1990","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2024.173878_bb0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-2999(83)90445-4","article-title":"Substance P excitation of rat locus coeruleus neurones","volume":"94","author":"Cheeseman","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173878_bb0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000125544","article-title":"Substance P stimulates arginine vasopressin and inhibits adrenocorticotropin release in vivo in the rat","volume":"52","author":"Chowdrey","year":"1990","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pbb.2024.173878_bb0175","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0889-8529(18)30191-9","article-title":"Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis. The corticotropin-releasing hormone perspective","volume":"21","author":"Chrousos","year":"1992","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.pbb.2024.173878_bb0180","doi-asserted-by":"crossref","first-page":"12077","DOI":"10.3390\/ijms222112077","article-title":"Role of oxytocin and vasopressin in neuropsychiatric disorders: therapeutic potential of agonists and antagonists","volume":"22","author":"Cid-Jofr\u00e9","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pbb.2024.173878_bb0185","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-2826.2010.02003.x","article-title":"Hippocampal microinfusion of oxytocin attenuates the behavioural response to stress by means of dynamic interplay with the glucocorticoid-catecholamine responses","volume":"22","author":"Cohen","year":"2010","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.pbb.2024.173878_bb0190","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/npp.2011.230","article-title":"The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder","volume":"37","author":"Cohen","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb0195","doi-asserted-by":"crossref","first-page":"17024","DOI":"10.1038\/nrdp.2017.24","article-title":"Anxiety disorders","volume":"3","author":"Craske","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.pbb.2024.173878_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1985.tb29900.x","article-title":"Comparative distribution of cholecystokinin and other neuropeptides","volume":"448","author":"Crawley","year":"1985","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pbb.2024.173878_bb0205","doi-asserted-by":"crossref","first-page":"319","DOI":"10.31887\/DCNS.2015.17.3\/macrocq","article-title":"A history of anxiety: from Hippocrates to DSM","volume":"17","author":"Crocq","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0210","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/npp.2011.73","article-title":"Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli","volume":"36","author":"Dannlowski","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb0215","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/cne.21212","article-title":"Hypothalamic and brainstem sources of pituitary adenylate cyclase-activating polypeptide nerve fibers innervating the hypothalamic paraventricular nucleus in the rat","volume":"500","author":"Das","year":"2007","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pbb.2024.173878_bb0220","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-6147(92)90014-W","article-title":"The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety","volume":"13","author":"Davis","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2024.173878_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/npp.2009.109","article-title":"Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety","volume":"35","author":"Davis","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb0230","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0196-9781(99)00154-0","article-title":"Anxiogenic effects of substance P and its 7\u201311 C terminal, but not the 1\u20137 N terminal, injected into the dorsal periaqueductal gray\u2606","volume":"20","author":"De Ara\u00fajo","year":"1999","journal-title":"Peptides (N.Y.)"},{"key":"10.1016\/j.pbb.2024.173878_bb0235","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0196-9781(99)00154-0","article-title":"Anxiogenic effects of substance P and its 7\u201311 C terminal, but not the 1\u20137 N terminal, injected into the dorsal periaqueductal gray\u2606","volume":"20","author":"De Ara\u00fajo","year":"1999","journal-title":"Peptides (N.Y.)"},{"key":"10.1016\/j.pbb.2024.173878_bb0240","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1471-4159.2005.03164.x","article-title":"Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists","volume":"94","author":"De Groote","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2024.173878_bb0245","series-title":"Peptides and Behavior, in: Memory and Transfer of Information","first-page":"373","author":"de Wied","year":"1973"},{"key":"10.1016\/j.pbb.2024.173878_bb0250","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0028-3908(65)90005-5","article-title":"The influence of the posterior and inter-mediate lobe of the pituitary and pituitary peptides on the maintenance of a conditioned avoidance response in rats","volume":"4","author":"De Wied","year":"1965","journal-title":"Int. J. Neuropharmacol."},{"key":"10.1016\/j.pbb.2024.173878_bb0255","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0306-4522(93)90026-C","article-title":"Distribution and co-localization of 5-hydroxy- tryptamine, thyrotropin-releasing hormone and substance p in the cat medulla","volume":"57","author":"Dean","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2024.173878_bb0260","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuroscience.2012.05.022","article-title":"Cholecystokinin knock-down in the basolateral amygdala has anxiolytic and antidepressant-like effects in mice","volume":"218","author":"Del Boca","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2024.173878_bb0265","series-title":"Depression and Other Common Mental Disorders Global Health Estimates","year":"2017"},{"key":"10.1016\/j.pbb.2024.173878_bb0270","doi-asserted-by":"crossref","DOI":"10.2174\/1874467210666170109164430","article-title":"The multi-faceted profile of corticotropin-releasing factor (CRF) family of neuropeptides and of their receptors on the paracrine\/local regulation of the inflammatory response","volume":"11","author":"Dermitzaki","year":"2018","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173878_bb0275","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0091-3057(94)90467-7","article-title":"Heterogeneity of CCK-B receptors involved in animal models of anxiety","volume":"49","author":"Derrien","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2024.173878_bb0280","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/npp.2012.147","article-title":"PACAP and the PAC1 receptor in post-traumatic stress disorder","volume":"38","author":"Dias","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb0285","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/npp.2013.113","article-title":"CRF mediates the anxiogenic and anti-rewarding, but not the anorectic effects of PACAP","volume":"38","author":"Dore","year":"2013","journal-title":"Neuropsycho- pharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb0290","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0361-9230(90)90061-4","article-title":"A substance P projection from the VMH to the dorsal midbrain central gray: implication for lordosis","volume":"25","author":"Dornan","year":"1990","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2024.173878_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2009.07.024","article-title":"Behavioral phenotyping of neuropeptide S receptor knockout mice","volume":"205","author":"Duangdao","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0300","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/(SICI)1096-9861(19981221)402:3<372::AID-CNE6>3.0.CO;2-2","article-title":"Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains","volume":"402","author":"Dumont","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pbb.2024.173878_bb0305","series-title":"Chapter IX Neuropeptide Y, Peptide YY and Pancreatic Polypeptide Receptor Proteins and mRNAs in Mammalian Brains","first-page":"375","author":"Dumont","year":"2000"},{"key":"10.1016\/j.pbb.2024.173878_bb0310","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1073\/pnas.0400794101","article-title":"Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats","volume":"101","author":"Ebner","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pbb.2024.173878_bb0315","series-title":"Substance P in the Medial Amygdala: Emotional Stress-Sensitive Release and Modulation of Anxiety-Related Behavior in Rats","author":"Ebner","year":"2004"},{"key":"10.1016\/j.pbb.2024.173878_bb0320","series-title":"Annals of the New York Academy of Sciences","first-page":"61","article-title":"Substance P in stress and anxiety: NK-1 receptor antagonism interacts with key brain areas of the stress circuitry","author":"Ebner","year":"2008"},{"key":"10.1016\/j.pbb.2024.173878_bb0325","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbr.2006.12.009","article-title":"Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice","volume":"178","author":"Egashira","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0330","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0006-8993(78)90590-5","article-title":"Substance P in the amygdaloid complex, bed nucleus and stria terminalis of the rat brain","volume":"149","author":"Emson","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0335","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.yfrne.2004.09.001","article-title":"The hypothalamic\u2013neurohypophysial system regulates the hypothalamic\u2013pituitary\u2013adrenal axis under stress: an old concept revisited","volume":"25","author":"Engelmann","year":"2004","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.pbb.2024.173878_bb0340","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yfrne.2006.07.002","article-title":"Physiology and gene regulation of the brain NPY Y1 receptor","volume":"27","author":"Eva","year":"2006","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.pbb.2024.173878_bb0345","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1210\/me.2013-1095","article-title":"Regulation of hypothalamic corticotropin-releasing hormone transcription by elevated glucocorticoids","volume":"27","author":"Evans","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.pbb.2024.173878_bb0350","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/14737175.2023.2211767","article-title":"Pharmacological treatment of generalised anxiety disorder: current practice and future directions","volume":"23","author":"Fagan","year":"2023","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.pbb.2024.173878_bb0355","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0006-8993(91)90378-9","article-title":"Inhibition of CRH-41 release by substance P, but not substance K, from the rat hypothalamus in vitro","volume":"538","author":"Faria","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0360","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0143-4179(90)90054-3","article-title":"The effects of two FMRFamide related peptides (A-18-F-amide and F-8-F-amide; \u2018morphine modulating peptides\u2019) on the endocrine and exocrine rat pancreas","volume":"17","author":"Fehmann","year":"1990","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pbb.2024.173878_bb0365","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1523\/JNEUROSCI.21-11-04111.2001","article-title":"Injections of the NMDA receptor antagonist aminophosphonopentanoic acid into the lateral nucleus of the amygdala block the expression of fear-potentiated startle and freezing","volume":"21","author":"Fendt","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0370","series-title":"Neurobiology of Anxiety Disorders and Implications for Treatment","author":"Garakani","year":"2006"},{"key":"10.1016\/j.pbb.2024.173878_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.595584","article-title":"Pharmacotherapy of anxiety disorders: current and emerging treatment options","author":"Garakani","year":"2020","journal-title":"Front. Psych."},{"key":"10.1016\/j.pbb.2024.173878_bb0380","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuroscience.2011.11.046","volume":"202","author":"Gaszner","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2024.173878_bb0385","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0166-4328(02)00054-2","article-title":"The role of lateral septal NK1 receptors in mediating anxiogenic effects induced by intracerebroventricular injection of substance P","volume":"134","author":"Gavioli","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0390","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2004.12.030","article-title":"Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor","volume":"509","author":"Gehlert","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173878_bb0395","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1176\/ajp.2006.163.4.637","article-title":"Elevated cerebrospinal fluid substance P concentrations in posttraumatic stress disorder and major depression","volume":"163","author":"Geracioti","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173878_bb0400","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1101\/lm.37601","article-title":"Contextual and auditory fear conditioning are mediated by the lateral, basal, and central amygdaloid nuclei in rats","volume":"8","author":"Goosens","year":"2001","journal-title":"Learn. Mem."},{"key":"10.1016\/j.pbb.2024.173878_bb0405","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(93)90095-Y","article-title":"Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat","volume":"237","author":"Gouard\u00e8res","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173878_bb0410","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2009.02.033","article-title":"Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors","volume":"1266","author":"Goyal","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0415","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0196-9781(92)90074-D","article-title":"Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat","volume":"13","author":"Gray","year":"1992","journal-title":"Peptides (N.Y.)"},{"key":"10.1016\/j.pbb.2024.173878_bb0420","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1038\/npp.2012.136","article-title":"Central vasopressin V1A receptor blockade impedes hypothalamic\u2013pituitary\u2013adrenal habituation to repeated restraint stress exposure in adult male rats","volume":"37","author":"Gray","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb0425","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.psyneuen.2008.12.013","article-title":"Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior","volume":"34","author":"Hammack","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pbb.2024.173878_bb0430","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/cne.10418","article-title":"Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study","volume":"453","author":"Hannibal","year":"2002","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pbb.2024.173878_bb0435","doi-asserted-by":"crossref","first-page":"13355","DOI":"10.1073\/pnas.231094498","article-title":"Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP)","volume":"98","author":"Hashimoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pbb.2024.173878_bb0440","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1471-4159.2009.06168.x","article-title":"Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone","volume":"110","author":"Hashimoto","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2024.173878_bb0445","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.neulet.2009.11.019","article-title":"Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder","volume":"468","author":"Hashimoto","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2024.173878_bb0450","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/sj.mp.4001945","article-title":"A novel DISC1-interacting partner DISC1-binding zinc-finger protein: implication in the modulation of DISC1-dependent neurite outgrowth","volume":"12","author":"Hattori","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173878_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2004.05.002","article-title":"The NPY system in stress, anxiety and depression","author":"Heilig","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pbb.2024.173878_bb0460","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/npp.1993.35","article-title":"Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects","volume":"8","author":"Heilig","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb0465","series-title":"Immunohistochemical Localization of the Vasopressin V1b Receptor in the Rat Brain and Pituitary Gland: Anatomical Support for Its Involvement in the Central Effects of Vasopressin*","author":"Hernando","year":"2001"},{"key":"10.1016\/j.pbb.2024.173878_bb0470","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1523\/JNEUROSCI.07-09-02967.1987","article-title":"Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists","volume":"7","author":"Hill","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0475","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1023\/A:1026499604848","article-title":"Rapid non-genomic feedback effects of glucocorticoids on CRF-induced ACTH secretion in rats","volume":"17","author":"Hinz","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0480","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s10194-018-0855-1","article-title":"Discovery of PACAP and its receptors in the brain","volume":"19","author":"Hirabayashi","year":"2018","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.pbb.2024.173878_bb0485","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejphar.2014.02.027","article-title":"Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behavior","volume":"730","author":"Hodgson","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173878_bb0490","series-title":"Evolution of the Nervous System Evolution of Vertebrate Neuropeptides","author":"Holmgren","year":"2001"},{"key":"10.1016\/j.pbb.2024.173878_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2019.101993","article-title":"Substance P: a neuropeptide involved in the psychopathology of anxiety disorders","author":"Iftikhar","year":"2020","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pbb.2024.173878_bb0500","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1073\/pnas.77.11.6917","article-title":"Distinct cholecystokinin receptors in brain and pancreas","volume":"77","author":"Innis","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2024.173878_bb0505","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neures.2009.11.004","article-title":"Involvement of vasopressin V1b receptor in anti-anxiety action of SSRI and SNRI in mice","volume":"66","author":"Ishizuka","year":"2010","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0510","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.neuroscience.2003.10.015","article-title":"N-methyl-d-aspartate receptors in the amygdala are necessary for the acquisition and expression of conditioned defeat","volume":"123","author":"Jasnow","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2024.173878_bb0515","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/10253890009001125","article-title":"Substance P is involved in terminating the hypothalamo-pituitary-adrenal axis response to acute stress through centrally located neurokinin-1 receptors","volume":"3","author":"Jessop","year":"2000","journal-title":"Stress"},{"key":"10.1016\/j.pbb.2024.173878_bb0520","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/298245a0","article-title":"Cloning and sequence analysis of cDNA for porcine \u03b2-neo-endorphin\/dynorphin precursor","volume":"298","author":"Kakidani","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2024.173878_bb0525","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(96)00838-2","article-title":"Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam","volume":"317","author":"Kask","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173878_bb0530","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0306-4522(01)00116-6","article-title":"Neuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety","volume":"104","author":"Kask","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2024.173878_bb0535","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0149-7634(01)00066-5","article-title":"The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y","volume":"26","author":"Kask","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2024.173878_bb0540","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1432-0436.1995.5930163.x","article-title":"Distribution and developmental changes in vasopressin V2 receptor mRNA in rat brain","volume":"59","author":"Kato","year":"1995","journal-title":"Differentiation"},{"key":"10.1016\/j.pbb.2024.173878_bb0545","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/7854_2009_9","article-title":"Epidemiology of anxiety disorders","volume":"2","author":"Kessler","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0550","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/frne.1995.1011","article-title":"The history of neuropeptides I","volume":"16","author":"Klavdieva","year":"1995","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.pbb.2024.173878_bb0560","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0014-2999(84)90647-2","article-title":"Cholecystokinin-octapeptide fragments: binding to brain cholecystokinin receptors","volume":"105","author":"Knight","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173878_bb0565","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0306-4522(01)00463-8","article-title":"Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization","volume":"111","author":"Kopp","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2024.173878_bb0570","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.npep.2013.10.014","article-title":"Role of neuropeptides in anxiety, stress, and depression: from animals to humans","volume":"47","author":"Kormos","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pbb.2024.173878_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2013.10.014","article-title":"Role of neuropeptides in anxiety, stress, and depression: from animals to humans","author":"Kormos","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pbb.2024.173878_bb0580","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1152\/physrev.00035.2011","article-title":"Vasopressin V1a and V1b receptors: from molecules to physiological systems","volume":"92","author":"Koshimizu","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pbb.2024.173878_bb0585","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.brainresbull.2012.06.001","article-title":"Microinjection of RFRP-1 in the central nucleus of amygdala decreases food intake in the rat","volume":"88","author":"Kov\u00e1cs","year":"2012","journal-title":"Brain Res. Bull."},{"issue":"281","key":"10.1016\/j.pbb.2024.173878_bb0590","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1126\/science.281.5383.1640","article-title":"Distinct mechanism for antidepressant activity by blockade of central substance P receptors","volume":"1979","author":"Kramer","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pbb.2024.173878_bb0595","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.biopsycho.2013.02.018","article-title":"Neuropeptide S receptor gene is associated with cortisol responses to social stress in humans","volume":"93","author":"Kumsta","year":"2013","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.pbb.2024.173878_bb0600","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1007\/s00018-008-8160-9","article-title":"Galanin \u2013 25 years with a multitalented neuropeptide","volume":"65","author":"Kuteeva","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.pbb.2024.173878_bb0605","series-title":"Neuropeptides in Anxiety Modulation","author":"Landgraf","year":"2005"},{"key":"10.1016\/j.pbb.2024.173878_bb0610","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/cne.903160304","article-title":"Distribution of substance P-immunoreactive elements in the preoptic area and the hypothalamus of the rat","volume":"316","author":"Larsen","year":"1992","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pbb.2024.173878_bb0615","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2826.1993.tb00368.x","article-title":"Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a central mechanism involving corticotrophin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus","volume":"5","author":"Larsen","year":"1993","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.pbb.2024.173878_bb0620","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.neuro.23.1.155","article-title":"Emotion circuits in the brain","volume":"23","author":"Ledoux","year":"2000","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2009.04.001","article-title":"Oxytocin: the great facilitator of life","author":"Lee","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pbb.2024.173878_bb0630","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2013.00100","article-title":"A novel V1a receptor antagonist blocks vasopressin-induced changes in the CNS response to emotional stimuli: an fMRI study","volume":"7","author":"Lee","year":"2013","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0635","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1076\/apab.110.1.90.899","article-title":"Hypothalamic-pituitary-adrenal function","volume":"110","author":"Lightman","year":"2002","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.pbb.2024.173878_bb0640","series-title":"Send Orders of Reprints at reprints@benthamscience.org Current Pharmaceutical Design","author":"Lin","year":"2012"},{"key":"10.1016\/j.pbb.2024.173878_bb0645","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/CJP.CJP_23_19","article-title":"Neuropeptide FF modulates neuroendocrine and energy homeostasis through hypothalamic signaling","volume":"62","author":"Lin","year":"2019","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.pbb.2024.173878_bb0650","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3390\/ijms18081810","article-title":"NPFFR2 activates the HPA Axis and induces anxiogenic effects in rodents","volume":"18","author":"Lin","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pbb.2024.173878_bb0655","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.3390\/cells9112479","article-title":"Ablation of NPFFR2 in mice reduces response to single prolonged stress model","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.pbb.2024.173878_bb0660","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/cne.22603","article-title":"Molecular fingerprint of neuropeptide s-producing neurons in the mouse brain","volume":"519","author":"Liu","year":"2011","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pbb.2024.173878_bb0665","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0167-0115(01)00256-7","article-title":"Comparative analysis of the central CCK system in fawn hooded and Wistar Kyoto rats: extended localisation of CCK-A receptors throughout the rat brain using a novel radioligand","volume":"99","author":"Lodge","year":"2001","journal-title":"Regul. Pept."},{"key":"10.1016\/j.pbb.2024.173878_bb0670","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0924-977X(97)00046-1","article-title":"Cholecystokinin in CSF from depressed patients: possible relations to severity of depression and suicidal behaviour","volume":"8","author":"L\u00f6fberg","year":"1998","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2024.173878_bb0675","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1210\/en.2006-1309","article-title":"The hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptors","volume":"148","author":"Lolait","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.pbb.2024.173878_bb0680","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2826.2007.01560.x","article-title":"Attenuated stress response to acute lipopolysaccharide challenge and ethanol administration in vasopressin V1b receptor knockout mice","volume":"19","author":"Lolait","year":"2007","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.pbb.2024.173878_bb0685","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.yhbeh.2017.10.007","article-title":"Consequences of continuous social defeat stress on anxiety- and depressive-like behaviors and ethanol reward in mice","volume":"97","author":"Macedo","year":"2018","journal-title":"Horm. Behav."},{"key":"10.1016\/j.pbb.2024.173878_bb0690","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1523\/JNEUROSCI.09-01-00258.1989","article-title":"Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues","volume":"9","author":"Mantyh","year":"1989","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0695","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1146\/annurev.neuro.24.1.897","article-title":"Neurobiology of Pavlovian fear conditioning","volume":"24","author":"Maren","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0700","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1037\/0735-7044.110.6.1365","article-title":"N-methyl-D-aspartate receptors in the basolateral amygdala are required for both acquisition and expression of conditional fear in rats","volume":"110","author":"Maren","year":"1996","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0705","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nm0698-718","article-title":"Role of the Y5 neuropeptide Y receptor in feeding and obesity","volume":"4","author":"Marsh","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.pbb.2024.173878_bb0710","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.psc.2009.05.004","article-title":"The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology","volume":"32","author":"Martin","year":"2009","journal-title":"Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.pbb.2024.173878_bb0715","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0006-8993(79)90666-8","article-title":"The excitatory action of substance P and stimulation of the stria terminalis bed nucleus on preoptic neurones","volume":"166","author":"Mayer","year":"1979","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0720","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3940(97)00197-3","article-title":"Histochemistry in rat brain and spinal cord with an antibody directed at the cholecystokininA receptor","volume":"225","author":"Mercer","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2024.173878_bb0725","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-8993(96)00477-5","article-title":"On the distribution of cholecystokinin B receptors in monkey brain","volume":"738","author":"Mercer","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0730","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/mp.2008.54","article-title":"Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans","volume":"14","author":"Meyer-Lindenberg","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173878_bb0735","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/hmg\/9.9.1415","article-title":"Disruption of two novel genes by a translocation co-segregating with schizophrenia","volume":"9","author":"Millar","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pbb.2024.173878_bb0740","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2009.09.077","article-title":"A possible role of neuropeptide Y in depression and stress","volume":"1314","author":"Morales-Medina","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0745","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2011.06.030","article-title":"Role of neuropeptide Y Y1 and Y2 receptors on behavioral despair in a rat model of depression with co-morbid anxiety","volume":"62","author":"Morales-Medina","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb0750","first-page":"1","article-title":"Neurobiology of cholecystokinin","volume":"9","author":"Moran","year":"1994","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.pbb.2024.173878_bb0755","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0006-8993(86)91413-7","article-title":"Two brain cholecystokinin receptors: implications for behavioral actions","volume":"362","author":"Moran","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0760","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.expneurol.2012.06.026","article-title":"Neuroanatomy of the extended circadian rhythm system","volume":"243","author":"Morin","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pbb.2024.173878_bb0765","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/278423a0","article-title":"Nucleotide sequence of cloned cDNA for bovine corticotropin-\u03b2-lipotropin precursor","volume":"278","author":"Nakanishi","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2024.173878_bb0770","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tins.2012.08.004","article-title":"Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors","volume":"35","author":"Neumann","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0775","doi-asserted-by":"crossref","first-page":"12387","DOI":"10.1021\/acs.jmedchem.0c00643","article-title":"Neuropeptide FF and its receptors: therapeutic applications and ligand development","volume":"63","author":"Nguyen","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2024.173878_bb0780","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0306-4522(92)90401-M","article-title":"Serotonin-, substance P- and glutamate\/aspartate-like immunoreactivities in medullo-spinal pathways of rat and primate","volume":"48","author":"Nicholas","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2024.173878_bb0785","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/295202a0","article-title":"Cloning and sequence analysis of cDNA for bovine adrenal prepro- enkephalin","volume":"295","author":"Noda","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2024.173878_bb0790","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.pnpbp.2007.06.026","article-title":"Gender-specific association of a functional coding polymorphism in the neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit\/hyper-activity disorder","volume":"31","author":"Okamura","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173878_bb0795","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1601-183X.2008.00389.x","article-title":"Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice","volume":"7","author":"Painsipp","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.pbb.2024.173878_bb0800","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pneurobio.2007.10.008","article-title":"Urocortin and the brain","volume":"84","author":"Pan","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pbb.2024.173878_bb0805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/jn.00153.2004","article-title":"New vistas on amygdala networks in conditioned fear","volume":"92","author":"Par\u00e9","year":"2004","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pbb.2024.173878_bb0810","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1046\/j.1460-9568.1999.00553.x","article-title":"Regional distribution of Y-receptor subtype mRNAs in rat brain","volume":"11","author":"Parker","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0815","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0196-9781(01)00610-6","article-title":"Pancreatic polypeptide receptors: affinity, sodium sensitivity and stability of agonist binding","volume":"23","author":"Parker","year":"2002","journal-title":"Peptides (N.Y.)"},{"key":"10.1016\/j.pbb.2024.173878_bb0820","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0165-0173(01)00080-7","article-title":"Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems","volume":"38","author":"Petrovich","year":"2001","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.pbb.2024.173878_bb0825","doi-asserted-by":"crossref","first-page":"990","DOI":"10.2174\/138161211795589328","article-title":"The role of the PACAP signaling system in depression","volume":"17","author":"Pinhasov","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pbb.2024.173878_bb0830","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0143-4179(97)90001-9","article-title":"The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation","volume":"31","author":"Quartara","year":"1997","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pbb.2024.173878_bb0835","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.physbeh.2013.02.007","article-title":"Repeated intranasal oxytocin administration in early life dysregulates the HPA axis and alters social behavior","volume":"112\u2013113","author":"Rault","year":"2013","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2024.173878_bb0840","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/S0024-3205(02)02159-8","article-title":"Neuropeptide Y (NPY) and depression: from animal studies to the human condition","volume":"71","author":"Redrobe","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2024.173878_bb0845","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s12031-012-9762-0","article-title":"PACAP is an endogenous protective factor\u2014insights from PACAP-deficient mice","volume":"48","author":"Reglodi","year":"2012","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/j.pbb.2024.173878_bb0850","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0024-3205(87)90349-3","article-title":"Pharmacological receptors for substance P and neurokinins","volume":"40","author":"Regoli","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2024.173878_bb0855","first-page":"551","article-title":"Receptors and antagonists for substance P and related peptides","volume":"46","author":"Regoli","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbb.2024.173878_bb0860","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1985.tb07105.x","article-title":"Neuronal cholecystokinin: one or multiple transmitters?","volume":"44","author":"Rehfeld","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2024.173878_bb0865","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.npep.2015.09.008","article-title":"Neuropeptide Y: a stressful review","volume":"55","author":"Reichmann","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pbb.2024.173878_bb0870","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature09856","article-title":"Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor","volume":"470","author":"Ressler","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2024.173878_bb0875","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1054\/npep.2000.0834","article-title":"Neuroanatomical localisation of substance P in the CNS and sensory neurons","volume":"34","author":"Ribeiro-da-Silva","year":"2000","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pbb.2024.173878_bb0880","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00213-005-0293-z","article-title":"Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications","volume":"185","author":"Ring","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2024.173878_bb0885","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0306-4522(82)90156-7","article-title":"Distribution of neuropeptides in the limbic system of the rat: the amygdaloid complex","volume":"7","author":"Roberts","year":"1982","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2024.173878_bb0890","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2019-321400","article-title":"The translational neural circuitry of anxiety","author":"Robinson","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173878_bb0895","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1523\/JNEUROSCI.21-17-06889.2001","article-title":"Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning","volume":"21","author":"Rodrigues","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0900","doi-asserted-by":"crossref","first-page":"9085","DOI":"10.1073\/pnas.1322868111","article-title":"Oxytocin promotes social bonding in dogs","volume":"111","author":"Romero","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pbb.2024.173878_bb0905","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1534582304265945","article-title":"The neurobiology of conditioned and unconditioned fear: a neuro-behavioral system analysis of the amygdala","volume":"3","author":"Rosen","year":"2004","journal-title":"Behav. Cogn. Neurosci. Rev."},{"key":"10.1016\/j.pbb.2024.173878_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2019.104578","article-title":"Sex-dependent effects of social isolation on the regulation of arginine-vasopressin (AVP) V1a, oxytocin (OT) and serotonin (5HT) 1a receptor binding and aggression","volume":"116","author":"Ross","year":"2019","journal-title":"Horm. Behav."},{"key":"10.1016\/j.pbb.2024.173878_bb0915","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.peptides.2012.01.024","article-title":"[tBu-d-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies","volume":"34","author":"Ruzza","year":"2012","journal-title":"Peptides (N.Y.)"},{"key":"10.1016\/j.pbb.2024.173878_bb0920","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0028-3908(02)00234-4","article-title":"Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats","volume":"43","author":"Sajdyk","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb0925","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0091-3057(01)00679-7","article-title":"Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala","volume":"71","author":"Sajdyk","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2024.173878_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2004.05.006","article-title":"Interactions between NPY and CRF in the amygdala to regulate emotionality","author":"Sajdyk","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pbb.2024.173878_bb0935","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1523\/JNEUROSCI.0659-07.2008","article-title":"Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic\u2013adrenal\u2013pituitary axis activity or hyperthermia","volume":"28","author":"Sajdyk","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0940","first-page":"55","article-title":"How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions*","volume":"21","author":"Sapolsky","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.pbb.2024.173878_bb0945","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0092-8674(02)01116-9","article-title":"Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear","volume":"111","author":"Shumyatsky","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.pbb.2024.173878_bb0950","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuropharm.2009.06.038","article-title":"Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats","volume":"58","author":"Slattery","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb0955","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuro-endocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb0960","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1210\/en.2005-1280","article-title":"Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake","volume":"147","author":"Smith","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.pbb.2024.173878_bb0965","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jnr.20200","article-title":"Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation","volume":"77","author":"S\u00f8rensen","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pbb.2024.173878_bb0970","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.biopsych.2005.10.012","article-title":"Brain mechanisms of fear extinction: historical perspectives on the contribution of prefrontal cortex","volume":"60","author":"Sotres-Bayon","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173878_bb0975","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neuroscience.2005.12.051","article-title":"Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons","volume":"138","author":"Spiga","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2024.173878_bb0980","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/cne.21046","article-title":"Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals","volume":"499","author":"Stani\u0107","year":"2006","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pbb.2024.173878_bb0985","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1176\/appi.ajp.2014.14010003","article-title":"Anxiety disorders, obsessive-compulsive and related disorders, trauma- and stressor-related disorders, and dissociative disorders in DSM-5","volume":"171","author":"Stein","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173878_bb0990","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuron.2012.09.025","article-title":"Neuromodulation by oxytocin and vasopressin","volume":"76","author":"Stoop","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2024.173878_bb0995","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.2011.05904.x","article-title":"PACAP: a master regulator of neuro-endocrine stress circuits and the cellular stress response","volume":"1220","author":"Stroth","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pbb.2024.173878_bb1000","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2013.00029","article-title":"Interactions of zebrafish peptide YYb with the neuropeptide Y-family receptors Y4, Y7, Y8a, and Y8b","volume":"7","author":"Sundstr\u00f6m","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb1005","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1001\/jama.2022.22744","article-title":"Anxiety disorders","volume":"328","author":"Szuhany","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.pbb.2024.173878_bb1010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125729","article-title":"Fear conditioning induced by interpersonal conflicts in healthy individuals","volume":"10","author":"Tada","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.pbb.2024.173878_bb1015","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.3390\/ijms22147287","article-title":"The role of neuropeptide Y in the nucleus accumbens","volume":"22","author":"Tanaka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pbb.2024.173878_bb1020","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.neuroscience.2008.11.048","article-title":"Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)\u2013Y4 receptor knockout mice","volume":"158","author":"Tasan","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2024.173878_bb1025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1460-9568.2003.02725.x","article-title":"Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors","volume":"18","author":"Tschenett","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb1030","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3999(02)00429-4","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis, neuroendocrine factors and stress","volume":"53","author":"Tsigos","year":"2002","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.pbb.2024.173878_bb1035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.regpep.2006.12.019","article-title":"Increased circulating cholecystokinin contri- butes to anorexia and anxiety behavior in mice overexpressing pancreatic polypeptide","volume":"141","author":"Ueno","year":"2007","journal-title":"Regul. Pept."},{"key":"10.1016\/j.pbb.2024.173878_bb1040","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/npp.2010.30","article-title":"Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response","volume":"35","author":"Unschuld","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb1045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1113\/jphysiol.1931.sp002763","article-title":"An unidentified depressor substance in certain tissue extracts","volume":"72","author":"v. Euler","year":"1931","journal-title":"J. Physiol."},{"key":"10.1016\/j.pbb.2024.173878_bb1050","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1523\/JNEUROSCI.04-04-01021.1984","article-title":"Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand","volume":"4","author":"Van Dijk","year":"1984","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb1055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/pr.109.001370","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery","volume":"61","author":"Vaudry","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbb.2024.173878_bb1060","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/378287a0","article-title":"Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor","volume":"378","author":"Vaughan","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2024.173878_bb1065","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1523\/JNEUROSCI.1787-13.2014","article-title":"Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of \u0394FosB","volume":"34","author":"Vialou","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb1070","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040839","article-title":"Corticotropin-releasing factor family: a stress hormone-receptor system\u2019s emerging role in mediating sex-specific signaling","volume":"9","author":"Vuppaladhadiam","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.pbb.2024.173878_bb1075","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3390\/cells9040839","article-title":"Corticotropin-releasing factor family: a stress hormone-receptor system\u2019s emerging role in mediating sex-specific signaling","volume":"9","author":"Vuppaladhadiam","year":"2020","journal-title":"Cells"},{"issue":"259","key":"10.1016\/j.pbb.2024.173878_bb1080","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.8380941","article-title":"Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides","volume":"1979","author":"Wahlestedt","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.pbb.2024.173878_bb1085","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1037\/0735-7044.114.6.1019","article-title":"Involvement of NMDA receptors within the amygdala in short- versus long-term memory for fear conditioning as assessed with fear-potentiated startle","volume":"114","author":"Walker","year":"2000","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb1090","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1523\/JNEUROSCI.21-10-03619.2001","article-title":"Neurotoxic lesions of the lateral nucleus of the amygdala decrease conditioned fear but not unconditioned fear of a predator odor: comparison with electrolytic lesions","volume":"21","author":"Wallace","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb1095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.1994.tb44052.x","article-title":"Cholecystokinin receptor family","volume":"713","author":"Wank","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pbb.2024.173878_bb1100","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2012.00146","article-title":"Galanin receptors and ligands","volume":"3","author":"Webling","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.pbb.2024.173878_bb1105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0167-0115(93)90431-7","article-title":"Neuropeptide Y: a central regulator of energy homeostasis","volume":"49","author":"White","year":"1993","journal-title":"Regul. Pept."},{"key":"10.1016\/j.pbb.2024.173878_bb1110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300290","article-title":"Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin","volume":"29","author":"Wigger","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb1115","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2015.00146","article-title":"Ancient interaction between the teneurin C-terminal associated peptides (TCAP) and latrophilin ligand-receptor coupling: a role in behavior","volume":"9","author":"Woelfle","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pbb.2024.173878_bb1120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cne.10823","article-title":"Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry","volume":"464","author":"Wolak","year":"2003","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pbb.2024.173878_bb1125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00213-002-1181-4","article-title":"Decreased CCK B receptor binding in rat amygdala in animals demonstrating greater anxiety-like behavior","volume":"164","author":"Wunderlich","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2024.173878_bb1130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cne.21159","article-title":"Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain","volume":"500","author":"Xu","year":"2007","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pbb.2024.173878_bb1135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000073702","article-title":"Transgenesis and the study of expression, cellular targeting and function of oxytocin, vasopressin and their receptors","volume":"78","author":"Young","year":"2003","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pbb.2024.173878_bb1140","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.3390\/ijms22147611","article-title":"Knockout of NPFFR2 prevents LPS-induced depressive-like responses in mice","volume":"22","author":"Yu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pbb.2024.173878_bb1145","series-title":"Sex Differences in Oxytocin and Vasopressin V1a Receptor Binding Densities in the Mouse Brain: Focus on the Social Behavior Neural Network","author":"Yuan","year":"2017"},{"key":"10.1016\/j.pbb.2024.173878_bb1150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/npp.2008.55","article-title":"Effects of substance P in the amygdala, ventromedial hypothalamus, and periaqueductal gray on fear-potentiated startle","volume":"34","author":"Zhao","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173878_bb1155","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2021.100942","article-title":"The role of oxytocin, vasopressin, and their receptors at nociceptors in peripheral pain modulation","volume":"63","author":"Zheng","year":"2021","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.pbb.2024.173878_bb1160","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.psyneuen.2010.01.012","article-title":"Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1","volume":"35","author":"Zhu","year":"2010","journal-title":"Psychoneuroendocrinology"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305724001722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305724001722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T13:51:59Z","timestamp":1733233919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305724001722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":231,"alternative-id":["S0091305724001722"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2024.173878","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anxiety and the brain: Neuropeptides as emerging factors","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2024.173878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"173878"}}